Gamma-interferon exerts a critical early restriction on replication and dissemination of yellow fever virus vaccine strain 17D-204

Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection In Vivo

(2017) Florian Douam et al.   mBio

Single-cell tracking of flavivirus RNA uncovers species-specific interactions with the immune system dictating disease outcome

(2017) Florian Douam et al.   Nature Communications

Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling

(2016) Alesha Grant et al.   Cell Host & Microbe

Yellow fever cases in Asia: primed for an epidemic

(2016) Sean Wasserman et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

A Yellow Fever Epidemic

(2016) Daniel Lucey et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Yellow fever continues to spread in Angola

(2016) Andrew Green   LANCET

Yellow Fever Remains a Potential Threat to Public Health

(2016) Pedro F.C. Vasconcelos et al.   VECTOR-BORNE AND ZOONOTIC DISEASES

Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses

(2016) Maria Dolores Fernandez-Garcia et al.   mBio

The 17D-204 Vaccine Strain-Induced Protection against Virulent Yellow Fever Virus Is Mediated by Humoral Immunity and CD4+ but not CD8+ T Cells

(2016) Alan M. Watson et al.   PLoS Pathogens

Current status and future prospects of yellow fever vaccines

(2015) Andrew S Beck et al.   Expert Review of Vaccines

A Single Amino Acid Substitution in the M Protein Attenuates Japanese Encephalitis Virus in Mammalian Hosts

(2015) Mélissanne de Wispelaere et al.   JOURNAL OF VIROLOGY

Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier

(2015) Helen M. Lazear et al.   Science Translational Medicine

Serious adverse events associated with yellow fever vaccine

(2015) Reinaldo de Menezes Martins et al.   Human Vaccines & Immunotherapeutics

The Essential, Nonredundant Roles of RIG-I and MDA5 in Detecting and Controlling West Nile Virus Infection

(2013) J. S. Errett et al.   JOURNAL OF VIROLOGY

Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010

(2013) J.G. Breugelmans et al.   VACCINE

IFN-γ-induced iNOS Expression in Mouse Regulatory Macrophages Prolongs Allograft Survival in Fully Immunocompetent Recipients

(2012) Paloma Riquelme et al.   MOLECULAR THERAPY

Systematic identification of type I and type II interferon-induced antiviral factors

(2012) S.-Y. Liu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain

(2012) Brett A. Thibodeaux et al.   VACCINE

Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate

(2012) Christina L. Gardner et al.   VIROLOGY

DENV Inhibits Type I IFN Production in Infected Cells by Cleaving Human STING

(2012) Sebastian Aguirre et al.   PLoS Pathogens

Mouse STAT2 Restricts Early Dengue Virus Replication

(2010) Joseph Ashour et al.   Cell Host & Microbe

CD8+ gamma-delta TCR+ and CD4+ T cells produce IFN-γ at 5–7 days after yellow fever vaccination in Indian rhesus macaques, before the induction of classical antigen-specific T cell responses

(2010) Patrícia C.C. Neves et al.   VACCINE

Similarities and Differences in Antagonism of Neuron Alpha/Beta Interferon Responses by Venezuelan Equine Encephalitis and Sindbis Alphaviruses

(2009) J. Yin et al.   JOURNAL OF VIROLOGY

A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability

(2009) Jian-Jong Liang et al.   VACCINE

A Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus Infection

(2009) Kathryn C. Meier et al.   PLoS Pathogens

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

(2008) Denis Gaucher et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Case of Yellow Fever Vaccine–Associated Viscerotropic Disease with Prolonged Viremia, Robust Adaptive Immune Responses, and Polymorphisms in CCR5 and RANTES Genes

(2008) Bali Pulendran et al.   JOURNAL OF INFECTIOUS DISEASES

E Protein Domain III Determinants of Yellow Fever Virus 17D Vaccine Strain Enhance Binding to Glycosaminoglycans, Impede Virus Spread, and Attenuate Virulence

(2008) E. Lee et al.   JOURNAL OF VIROLOGY

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

(2008) Troy D Querec et al.   NATURE IMMUNOLOGY